20172020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3122 Cancers
  • 11832 Microbiology and virology

International and National Collaboration Publications and projects within past five years.

Publications

Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

Zafar, S., Quixabeira, D. C. A., Kudling, T. V., Cervera-Carrascon, V., Santos, J. M., Grönberg-Vähä-Koskela, S., Zhao, F., Aronen, P., Heiniö, C., Havunen, R., Sorsa, S., Kanerva, A. & Hemminki, A., 12 Sep 2020, In : Cancer Gene Therapy. 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Comparison of clinically relevant oncolytic virus platforms for enhancing T-cell therapy of solid tumors

Cervera-Carrascon, V., Quixabeira, D. C. A., Havunen, R., Santos, J. M., Kutvonen, E., Clubb, J. H. A., Siurala, M., Heiniö, C., Zafar, S., Koivula, T., Lumen, D., Vaha, M., Garcia-Horsman, A., Airaksinen, A. J., Sorsa, S., Anttila, M., Hukkanen, V., Kanerva, A. & Hemminki, A., 26 Jun 2020, In : Molecular Therapy - Oncolytics. 17, p. 47-60 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity

Santos, J. M., Heiniö, C., Cervera-Carrascon, V., Quixabeira, D. C. A., Siurala, M., Havunen, R., Butzow, R., Zafar, S., de Gruijl, T., Lassus, H., Kanerva, A. & Hemminki, A., Jan 2020, In : Journal for Immunotherapy of Cancer. 8, 1, 15 p., e000188.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling

Heiniö, C., Havunen, R., Santos, J., de Lint, K., Cervera-Carrascon, V., Kanerva, A. & Hemminki, A., Apr 2020, In : Cells. 9, 4, 13 p., 798.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

Cervera-Carrascon, V., Quixabeira, D. C. A., Santos, J. M., Havunen, R., Zafar, S., Hemminki, O., Heiniö, C., Munaro, E., Siurala, M., Sorsa, S., Mirtti, T., Järvinen, P., Mildh, M., Nisen, H., Rannikko, A., Anttila, M., Kanerva, A. & Hemminki, A., 2020, In : OncoImmunology. 9, 1, 12 p., e1761229.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File